Intellia Therapeutics (NTLA) Shares Outstanding (Entity) (2015 - 2026)

Intellia Therapeutics (NTLA) Shares Outstanding (Entity) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Intellia Therapeutics 1.67 Bn 1.67 Bn - 140.02 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 140.13 Mn
Mar 31, 2026 120.45 Mn
Dec 31, 2025 116.32 Mn
Sep 30, 2025 115.79 Mn
Jun 30, 2025 105.33 Mn
Mar 31, 2025 103.54 Mn
Dec 31, 2024 102.03 Mn
Sep 30, 2024 101.80 Mn
Jun 30, 2024 98.29 Mn
Mar 31, 2024 96.33 Mn
Dec 31, 2023 93.00 Mn
Sep 30, 2023 89.10 Mn
Jun 30, 2023 88.35 Mn
Mar 31, 2023 88.10 Mn
Dec 31, 2022 87.10 Mn
Sep 30, 2022 76.59 Mn
Jun 30, 2022 76.00 Mn
Mar 31, 2022 75.62 Mn
Dec 31, 2021 70,894.00
Sep 30, 2021 74.34 Mn